$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 20 21 22 23 24 25 26 27 28 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 14.18 | 291 | 4,127 | 116,980 | 116.7 K to 117 K (+0.25 %) |
Aug 09 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 14.75 | 4,629 | 68,278 | 126,975 | 131.6 K to 127 K (-3.52 %) |
Jul 14 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 12.79 | 10,000 | 127,854 | 1,730,646 | 1.7 M to 1.7 M (-0.57 %) |
Jul 14 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 12.83 | 10,000 | 128,322 | 1,740,646 | 1.8 M to 1.7 M (-0.57 %) |
Jul 08 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 13.05 | 4,629 | 60,413 | 131,604 | 136.2 K to 131.6 K (-3.40 %) |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | BYERS BROOK H | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
Jun 15 2010 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Option Exercise | A | 14.37 | 8,250 | 118,553 | 8,250 | |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 2.88 | 4,000 | 11,520 | 61,348 | |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 2.88 | 4,000 | 11,520 | 65,348 | |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 15.85 | 4,000 | 63,400 | 288,116 | 292.1 K to 288.1 K (-1.37 %) |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 2.88 | 4,000 | 11,520 | 292,116 | 288.1 K to 292.1 K (+1.39 %) |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 15.71 | 4,000 | 62,840 | 288,116 | 292.1 K to 288.1 K (-1.37 %) |
May 18 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 2.88 | 4,000 | 11,520 | 292,116 | 288.1 K to 292.1 K (+1.39 %) |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 107,868 | |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 15.87 | 2,500 | 39,676 | 1,000 | 3.5 K to 1,000 (-71.43 %) |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 2,500 | 3,325 | 3,500 | 1,000 to 3.5 K (+250.00 %) |
Jun 11 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 14.23 | 10,000 | 142,344 | 1,750,646 | 1.8 M to 1.8 M (-0.57 %) |
Jun 11 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 14.06 | 10,000 | 140,577 | 1,760,646 | 1.8 M to 1.8 M (-0.56 %) |
Jun 11 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 14.05 | 4,629 | 65,032 | 136,233 | 140.9 K to 136.2 K (-3.29 %) |
Apr 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 110,368 | |
Apr 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 16.90 | 5,000 | 84,513 | 1,000 | 6 K to 1,000 (-83.33 %) |
Apr 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 5,000 | 6,650 | 6,000 | 1,000 to 6 K (+500.00 %) |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 15.51 | 4,629 | 71,803 | 140,862 | 145.5 K to 140.9 K (-3.18 %) |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 15.72 | 10,000 | 157,223 | 1,760,646 | 1.8 M to 1.8 M (-0.56 %) |
May 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 15.51 | 10,000 | 155,058 | 1,770,646 | 1.8 M to 1.8 M (-0.56 %) |
Apr 14 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 16.88 | 4,629 | 78,135 | 145,491 | 150.1 K to 145.5 K (-3.08 %) |
Apr 13 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 16.79 | 10,000 | 167,854 | 1,780,646 | 1.8 M to 1.8 M (-0.56 %) |
Apr 13 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 16.96 | 10,000 | 169,552 | 1,790,646 | 1.8 M to 1.8 M (-0.56 %) |
Mar 16 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 19.47 | 15,000 | 292,082 | 288,116 | 303.1 K to 288.1 K (-4.95 %) |
Mar 16 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 19.40 | 5,000 | 97,003 | 303,116 | 308.1 K to 303.1 K (-1.62 %) |
Mar 15 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 115,368 | |
Mar 15 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 19.39 | 2,500 | 48,472 | 1,000 | 3.5 K to 1,000 (-71.43 %) |
Mar 15 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 2,500 | 3,325 | 3,500 | 1,000 to 3.5 K (+250.00 %) |
Mar 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 19.40 | 10,000 | 194,043 | 1,800,646 | 1.8 M to 1.8 M (-0.55 %) |
Mar 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 19.19 | 10,000 | 191,946 | 1,810,646 | 1.8 M to 1.8 M (-0.55 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.21 | 1,758 | 33,771 | 85,050 | 86.8 K to 85.1 K (-2.03 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.21 | 837 | 16,079 | 40,500 | 41.3 K to 40.5 K (-2.02 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.21 | 848 | 16,290 | 41,056 | 41.9 K to 41.1 K (-2.02 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.21 | 43,257 | 830,967 | 2,093,316 | 2.1 M to 2.1 M (-2.02 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.63 | 2,258 | 44,325 | 86,808 | 89.1 K to 86.8 K (-2.54 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.63 | 1,075 | 21,102 | 41,337 | 42.4 K to 41.3 K (-2.53 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.63 | 1,090 | 21,397 | 41,904 | 43 K to 41.9 K (-2.54 %) |
Mar 11 2010 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 19.63 | 55,577 | 1,090,977 | 2,136,573 | 2.2 M to 2.1 M (-2.54 %) |
Mar 09 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 19.83 | 4,629 | 91,791 | 150,120 | 154.7 K to 150.1 K (-2.99 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | A | 17.18 | 65,000 | 1,116,700 | 65,000 | |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Option Exercise | A | 17.18 | 40,000 | 687,200 | 40,000 | |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | A | 17.18 | 55,000 | 944,900 | 55,000 | |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Option Exercise | A | 17.18 | 55,000 | 944,900 | 55,000 | |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 17.18 | 135,000 | 2,319,300 | 135,000 | |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,540 | 0 | 10,210 | 8.7 K to 10.2 K (+17.76 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 770 | 0 | 308,116 | 308.9 K to 308.1 K (-0.25 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 770 | 0 | 308,886 | 309.7 K to 308.9 K (-0.25 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,540 | 0 | 309,656 | 311.2 K to 309.7 K (-0.49 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 770 | 0 | 311,196 | 312 K to 311.2 K (-0.25 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,540 | 0 | 311,966 | 313.5 K to 312 K (-0.49 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.03 | 1,880 | 32,017 | 116,689 | 114.8 K to 116.7 K (+1.64 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.05 | 245 | 4,176 | 114,809 | 114.6 K to 114.8 K (+0.21 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.06 | 1,520 | 25,938 | 114,564 | 113 K to 114.6 K (+1.34 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.03 | 68,120 | 1,160,104 | 4,300,744 | 4.2 M to 4.3 M (+1.61 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.05 | 8,870 | 151,192 | 4,232,624 | 4.2 M to 4.2 M (+0.21 %) |
Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.06 | 55,080 | 939,907 | 4,223,754 | 4.2 M to 4.2 M (+1.32 %) |
Feb 16 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 117,868 | |
Feb 16 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 17.51 | 2,500 | 43,766 | 1,000 | 3.5 K to 1,000 (-71.43 %) |
Feb 16 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 2,500 | 3,325 | 3,500 | 1,000 to 3.5 K (+250.00 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 17.52 | 10,000 | 175,174 | 1,830,646 | 1.8 M to 1.8 M (-0.54 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 16.93 | 10,000 | 169,349 | 1,840,646 | 1.9 M to 1.8 M (-0.54 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 2,500 | 0 | 1,850,646 | 1.9 M to 1.9 M (-0.13 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 5,000 | 0 | 1,853,146 | 1.9 M to 1.9 M (-0.27 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 7,500 | 0 | 1,858,146 | 1.9 M to 1.9 M (-0.40 %) |
Feb 12 2010 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 15,000 | 0 | 1,865,646 | 1.9 M to 1.9 M (-0.80 %) |
Feb 11 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 17.14 | 4,629 | 79,354 | 145,491 | 150.1 K to 145.5 K (-3.08 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.98 | 27 | 458 | 113,044 | 113 K to 113 K (+0.02 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.93 | 196 | 3,318 | 113,017 | 112.8 K to 113 K (+0.17 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.04 | 6,178 | 105,282 | 112,821 | 106.6 K to 112.8 K (+5.79 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.15 | 607 | 10,411 | 106,643 | 106 K to 106.6 K (+0.57 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.93 | 30 | 508 | 106,036 | 106 K to 106 K (+0.03 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 17.03 | 385 | 6,555 | 106,006 | 105.6 K to 106 K (+0.36 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.87 | 599 | 10,108 | 105,621 | 105 K to 105.6 K (+0.57 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.93 | 220 | 3,725 | 105,022 | 104.8 K to 105 K (+0.21 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 16.85 | 1,195 | 20,138 | 104,802 | 103.6 K to 104.8 K (+1.15 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.98 | 971 | 16,485 | 4,168,674 | 4.2 M to 4.2 M (+0.02 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 7,100 | 120,199 | 4,167,703 | 4.2 M to 4.2 M (+0.17 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.04 | 223,822 | 3,814,240 | 4,160,603 | 3.9 M to 4.2 M (+5.69 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.15 | 21,979 | 376,988 | 3,936,781 | 3.9 M to 3.9 M (+0.56 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 1,070 | 18,118 | 3,914,802 | 3.9 M to 3.9 M (+0.03 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.03 | 13,943 | 237,395 | 3,913,732 | 3.9 M to 3.9 M (+0.36 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.87 | 21,703 | 366,219 | 3,899,789 | 3.9 M to 3.9 M (+0.56 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 7,975 | 135,026 | 3,878,086 | 3.9 M to 3.9 M (+0.21 %) |
Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.85 | 43,291 | 729,544 | 3,870,111 | 3.8 M to 3.9 M (+1.13 %) |
Jan 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 120,368 | |
Jan 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 17.25 | 5,000 | 86,250 | 1,000 | 6 K to 1,000 (-83.33 %) |
Jan 14 2010 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 5,000 | 6,650 | 6,000 | 1,000 to 6 K (+500.00 %) |
Jan 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 17.47 | 4,629 | 80,864 | 150,120 | 154.7 K to 150.1 K (-2.99 %) |
Dec 21 2009 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 20.12 | 5,000 | 100,623 | 388,278 | 393.3 K to 388.3 K (-1.27 %) |
Dec 16 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 20.39 | 5,000 | 101,950 | 313,506 | 318.5 K to 313.5 K (-1.57 %) |
Dec 15 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 20.42 | 2,000 | 40,843 | 1,000 | 3 K to 1,000 (-66.67 %) |
Dec 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.22 | 6,000 | 121,292 | 1,880,646 | 1.9 M to 1.9 M (-0.32 %) |
Dec 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.27 | 6,000 | 121,646 | 1,886,646 | 1.9 M to 1.9 M (-0.32 %) |
Dec 09 2009 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 20.26 | 4,629 | 93,806 | 154,749 | 159.4 K to 154.7 K (-2.90 %) |
Nov 17 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 19.19 | 15,000 | 287,906 | 318,506 | 333.5 K to 318.5 K (-4.50 %) |
Nov 17 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 19.26 | 5,000 | 96,301 | 333,506 | 338.5 K to 333.5 K (-1.48 %) |
Nov 13 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 665 | 884 | 125,368 | |
Nov 13 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 20.04 | 665 | 13,323 | 3,000 | 3.7 K to 3 K (-18.14 %) |
Nov 13 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 665 | 884 | 3,665 | 3 K to 3.7 K (+22.17 %) |
Nov 12 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 19.98 | 6,000 | 119,892 | 1,892,646 | 1.9 M to 1.9 M (-0.32 %) |
Nov 12 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.00 | 6,000 | 120,026 | 1,898,646 | 1.9 M to 1.9 M (-0.32 %) |
Nov 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 20.00 | 4,629 | 92,568 | 159,378 | 164 K to 159.4 K (-2.82 %) |
Oct 21 2009 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 20.65 | 5,000 | 103,230 | 393,278 | 398.3 K to 393.3 K (-1.26 %) |
Oct 15 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 20.42 | 5,000 | 102,117 | 338,506 | 343.5 K to 338.5 K (-1.46 %) |
Oct 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.36 | 6,000 | 122,160 | 1,904,646 | 1.9 M to 1.9 M (-0.31 %) |
Oct 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.96 | 6,000 | 125,760 | 1,910,646 | 1.9 M to 1.9 M (-0.31 %) |
Oct 07 2009 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 21.17 | 4,629 | 97,984 | 164,007 | 168.6 K to 164 K (-2.74 %) |
Sep 24 2009 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 21.13 | 5,000 | 105,670 | 398,278 | 403.3 K to 398.3 K (-1.24 %) |
Sep 16 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 20.73 | 5,000 | 103,632 | 343,506 | 348.5 K to 343.5 K (-1.43 %) |
Sep 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.63 | 6,000 | 123,780 | 1,916,646 | 1.9 M to 1.9 M (-0.31 %) |
Sep 14 2009 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.72 | 6,000 | 124,316 | 1,922,646 | 1.9 M to 1.9 M (-0.31 %) |
Sep 09 2009 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Sell | S | 20.12 | 4,629 | 93,144 | 168,636 | 173.3 K to 168.6 K (-2.67 %) |
Aug 27 2009 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 20.77 | 5,000 | 103,850 | 403,278 | 408.3 K to 403.3 K (-1.22 %) |
Aug 18 2009 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 19.53 | 5,000 | 97,659 | 348,506 | 353.5 K to 348.5 K (-1.41 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 126,033 | |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Sell | S | 20.00 | 5,000 | 100,000 | 3,000 | 8 K to 3 K (-62.50 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO & CFO | Buy | M | 1.33 | 5,000 | 6,650 | 8,000 | 3 K to 8 K (+166.67 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 19.60 | 54 | 1,058 | 103,607 | 103.6 K to 103.6 K (+0.05 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 19.99 | 1,785 | 35,681 | 103,553 | 101.8 K to 103.6 K (+1.75 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.60 | 1,962 | 38,455 | 3,826,820 | 3.8 M to 3.8 M (+0.05 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.99 | 64,668 | 1,292,687 | 3,824,858 | 3.8 M to 3.8 M (+1.72 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.60 | 1 | 20 | 194,184 | 194.2 K to 194.2 K (0.00 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.99 | 33 | 660 | 194,183 | 194.2 K to 194.2 K (+0.02 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.60 | 343 | 6,723 | 1,253,653 | 1.3 M to 1.3 M (+0.03 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.99 | 11,314 | 226,162 | 1,253,310 | 1.2 M to 1.3 M (+0.91 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.70 | 4,690 | 92,378 | 1,241,996 | 1.2 M to 1.2 M (+0.38 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.36 | 1,858 | 35,968 | 1,237,306 | 1.2 M to 1.2 M (+0.15 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.47 | 44 | 857 | 1,235,448 | 1.2 M to 1.2 M (0.00 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.37 | 5,623 | 108,893 | 1,235,404 | 1.2 M to 1.2 M (+0.46 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.48 | 1,454 | 28,323 | 1,229,781 | 1.2 M to 1.2 M (+0.12 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 19.50 | 2,208 | 43,055 | 1,228,327 | 1.2 M to 1.2 M (+0.18 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.70 | 26,808 | 528,034 | 3,760,190 | 3.7 M to 3.8 M (+0.72 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.36 | 10,624 | 205,665 | 3,733,382 | 3.7 M to 3.7 M (+0.29 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.47 | 249 | 4,848 | 3,722,758 | 3.7 M to 3.7 M (+0.01 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.37 | 32,139 | 622,394 | 3,722,509 | 3.7 M to 3.7 M (+0.87 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.48 | 8,312 | 161,912 | 3,690,370 | 3.7 M to 3.7 M (+0.23 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.50 | 12,622 | 246,124 | 3,682,058 | 3.7 M to 3.7 M (+0.34 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.70 | 14 | 276 | 194,150 | 194.1 K to 194.2 K (+0.01 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.36 | 5 | 97 | 194,136 | 194.1 K to 194.1 K (0.00 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.37 | 16 | 310 | 194,131 | 194.1 K to 194.1 K (+0.01 %) |